|
1
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: GLOBOCAN 2008 v2.0, Cancer incidence and
mortality worldwide: IARC CancerBase No. 10 [Internet].
International Agency for Research on Cancer, Lyon. 2010.29;2010.
http://globocan.iarc.fr/Default.aspxJuly
12–2012
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schwarte-Waldhoff I, Volpert OV, Bouck NP,
Sipos B, Hahn SA, Klein-Scory S, Lüttges J, Klöppel G, Graeven U,
Eilert-Micus C, et al: Smad4/DPC4-mediated tumor suppression
through suppression of angiogenesis. Proc Natl Acad Sci USA. 97:pp.
9624–9629. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao S, Venkatasubbarao K, Lazor JW,
Sperry J, Jin C, Cao L and Freeman JW: Inhibition of STAT3 Tyr705
phosphorylation by Smad4 suppresses transforming growth factor
beta-mediated invasion and metastasis in pancreatic cancer cells.
Cancer Res. 68:4221–4228. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee S, Cho YS, Shim C, Kim J, Choi J, Oh
S, Kim J, Zhang W and Lee J: Aberrant expression of Smad4 results
in resistance against the growth-inhibitory effect of transforming
growth factor-beta in the SiHa human cervical carcinoma cell line.
Int J Cancer. 94:500–507. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carmeliet P: Mechanisms of angiogenesis
and arteriogenesis. Nat Med. 6:389–395. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smith-McCune K, Zhu YH, Hanahan D and
Arbeit J: Cross-species comparison of angiogenesis during the
premalignant stages of squamous carcinogenesis in the human cervix
and K14-HPV16 transgenic mice. Cancer Res. 57:1294–1300.
1997.PubMed/NCBI
|
|
9
|
Veikkola T, Karkkainen M, Claesson-Welsh L
and Alitalo K: Regulation of angiogenesis via vascular endothelial
growth factor receptors. Cancer Res. 60:203–212. 2000.PubMed/NCBI
|
|
10
|
Dai Y, Zhang X, Peng Y and Wang Z: The
expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical
carcinoma. Gynecol Oncol. 97:96–103. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kodama J, Hashimoto I, Seki N, Hongo A,
Yoshinouchi M, Okuda H and Kudo T: Thrombospondin-1 and-2 Messenger
RNA Expression in Invasive Cervical Cancer: Correlation with
Angiogenesis and Prognosis. Clin Cancer Res. 7:2826–2831.
2001.PubMed/NCBI
|
|
12
|
Ren B, Yee KO, Lawler J and Khosravi-Far
R: Regulation of tumor angiogenesis by thrombospondin-1. Biochim
Biophys Acta. 1765:178–188. 2006.PubMed/NCBI
|
|
13
|
Chen C, Sun MZ, Liu S, Yeh D, Yu L, Song
Y, Gong L, Hao L, Hu J and Shao S: Smad4 mediates malignant
behaviors of human ovarian carcinoma cell through the effect on
expressions of E-cadherin, plasminogen activator inhibitor-1 and
VEGF. BMB Rep. 43:554–560. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lewin SN, Herzog TJ, Medel NI Barrena,
Deutsch I, Burke WM, Sun X and Wright JD: Comparative performance
of the 2009 international Federation of gynecology and obstetrics'
staging system for uterine corpus cancer. Obstet Gynecol.
116:1141–1149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Broders AC: Squamous cell epithelioma of
the skin: A study of 256 cases. Ann Surg. 73:141–160. 1921.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baldus SE, Schwarz E, Lohrey C, Zapatka M,
Landsberg S, Hahn SA, Schmidt D, Dienes HP, Schmiegel WH and
Schwarte-Waldhoff I: Smad4 deficiency in cervical carcinoma cells.
Oncogene. 24:810–819. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Van Trappen PO, Steele D, Lowe DG, Baithun
S, Beasley N, Thiele W, Weich H, Krishnan J, Shepherd JH, Pepper
MS, et al: Expression of vascular endothelial growth factor
(VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different
stages of cervical carcinogenesis. J Pathol. 201:544–554. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyaki M, Iijima T, Konishi M, Sakai K,
Ishii A, Yasuno M, Hishima T, Koike M, Shitara N, Iwama T, et al:
Higher frequency of Smad4 gene mutation in human colorectal cancer
with distant metastasis. Oncogene. 18:3098–3103. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kloth JN, Kenter GG, Spijker HS, Uljee S,
Corver WE, Jordanova ES, Fleuren GJ and Gorter A: Expression of
Smad2 and Smad4 in cervical cancer: Absent nuclear Smad4 expression
correlates with poor survival. Mod Pathol. 21:866–875. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hahn SA, Bartsch D, Schroers A, Galehdari
H, Becker M, Ramaswamy A, Schwarte-Waldhoff I, Maschek H and
Schmiegel W: Mutations of the DPC4/Smad4 gene in biliary tract
carcinoma. Cancer Res. 58:1124–1126. 1998.PubMed/NCBI
|
|
22
|
Bartsch D, Hahn SA, Danichevski KD,
Ramaswamy A, Bastian D, Galehdari H, Barth P, Schmiegel W, Simon B
and Rothmund M: Mutations of the DPC4/Smad4 gene in neuroendocrine
pancreatic tumors. Oncogene. 18:2367–2371. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Elliott RL and Blobe GC: Role of
transforming growth factor Beta in human cancer. J Clin Oncol.
23:2078–2093. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miyazono K, Suzuki H and Imamura T:
Regulation of TGF-beta signaling and its roles in progression of
tumors. Cancer Sci. 94:230–234. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schwarte-Waldhoff I and Schmiegel W: Smad4
transcriptional pathways and angiogenesis. Int J Gastrointest
Cancer. 31:47–59. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ke Z, Zhang X, Ma L and Wang L: Expression
of DPC4/Smad4 in non-small-cell lung carcinoma and its relationship
with angiogenesis. Neoplasma. 55:323–329. 2008.PubMed/NCBI
|
|
27
|
Kim MH, Seo SS, Song YS, Kang DH, Park IA,
Kang SB and Lee HP: Expression of cyclooxygenase-1 and-2 associated
with expression of VEGF in primary cervical cancer and at
metastatic lymph nodes. Gynecol Oncol. 90:83–90. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hasturk S, Kemp B, Kalapurakal SK, Kurie
JM, Hong WK and Lee JS: Expression of cyclooxygenase-1 and
cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung
carcinoma. Cancer. 94:1023–1031. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tokunaga T, Oshika Y, Abe Y, Ozeki Y,
Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N
and Nakamura M: Vascular endothelial growth factor (VEGF) mRNA
isoform expression pattern is correlated with liver metastasis and
poor prognosis in colon cancer. Br J Cancer. 77:998–1002. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maeda K, Chung YS, Ogawa Y, Takatsuka S,
Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular
endothelial growth factor expression in gastric carcinoma. Cancer.
77:858–863. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dameron KM, Volpert OV, Tainsky MA and
Bouck N: Control of angiogenesis in fibroblasts by p53 regulation
of thrombospondin-1. Science. 265:1582–1584. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin RJ, Kwak C, Lee SG, Lee CH, Soo CG,
Park MS, Lee E and Lee SE: The application of an anti-angiogenic
gene (thrombospondin-1) in the treatment of human prostate cancer
xenografts. Cancer Gene Ther. 7:1537–1542. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li X, Liu B, Xiao J, Yuan Y, Ma J and
Zhang Y: Roles of VEGF-C and Smad4 in the lymphangiogenesis,
lymphatic metastasis, and prognosis in colon cancer. J Gastrointest
Surg. 15:2001–2010. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Alvarez AA, Axelrod JR, Whitaker RS, Isner
PD, Bentley RC, Dodge RK and Rodriguez GC: Thrombospondin-1
expression in epithelial ovarian carcinoma: Association with p53
status, tumor angiogenesis, and survival in platinum-treated
patients. Gynecol Oncol. 82:273–278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Grossfeld GD, Ginsberg DA, Stein JP,
Bochner BH, Esrig D, Groshen S, Dunn M, Nichols PW, Taylor CR,
Skinner DG and Cote RJ: Thrombospondin-1 expression in bladder
cancer: Association with p53 alterations, tumor angiogenesis, and
tumor progression. J Natl Cancer Inst. 89:219–227. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grant SW, Kyshtoobayeva AS, Kurosaki T,
Jakowatz J and Fruehauf JP: Mutant p53 correlates with reduced
expression of thrombospondin-1, increased angiogenesis, and
metastatic progression in melanoma. Cancer Detect Prev. 22:185–194.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tokunaga T, Nakamura M, Oshika Y, Tsuchida
T, Kazuno M, Fukushima Y, Kawai K, Abe Y, Kijima H, Yamazaki H, et
al: Alterations in tumour suppressor gene p53 correlate with
inhibition of thrombospondin-1 gene expression in colon cancer
cells. Virchows Arch. 433:415–418. 1998. View Article : Google Scholar : PubMed/NCBI
|
